Lv21
190 积分 2025-07-11 加入
Mechanisms linking obesity to insulin resistance and type 2 diabetes
3小时前
待确认
Ectopic Fat in Insulin Resistance, Dyslipidemia, and Cardiometabolic Disease
4小时前
已完结
Type 2 diabetes mellitus
1个月前
已完结
Efficacy, Tolerability, and Safety of Glucagon-Like Peptide 1 Receptor Agonists (GLP1-RA) in Kidney Transplant Recipients With Diabetes
1个月前
已完结
Systematic review and meta-analysis on the effectiveness of multidisciplinary interventions to address polypharmacy in community-dwelling older adults
2个月前
已完结
Stroke patients with obstructive sleep Apnea: Risk of cardiovascular diseases - A systematic review and meta-analysis
2个月前
已完结
Once-weekly tirzepatide versus once-daily insulin degludec as add-on to metformin with or without SGLT2 inhibitors in patients with type 2 diabetes (SURPASS-3): a randomised, open-label, parallel-group, phase 3 trial
2个月前
已完结
Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial
2个月前
已完结
Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial
2个月前
已完结
Health Complications of Obesity: 224 Obesity-Associated Comorbidities from a Mechanistic Perspective
2个月前
已完结
皖公网安备34019202002308
